Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 12/2011

01-12-2011 | Article

Characterisation of uropathogenic Escherichia coli from children with urinary tract infection in different countries

Authors: N. L. Ramos, D. T. N. Dzung, K. Stopsack, V. Jankó, M. R. Pourshafie, M. Katouli, A. Brauner

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 12/2011

Login to get access

Abstract

Uropathogenic Escherichia coli (UPEC) carry many virulence factors, including those involved in long-term survival in the urinary tract. However, their prevalence and role among UPEC causing urinary tract infection (UTI) in children is not well studied. To further understand the virulence characteristics of these bacteria, we investigated the prevalence of antibiotic resistance, antigen 43 genes, curli and cellulose among UPEC in children from different countries. Isolates (n = 337) from five countries were tested for antibiotic susceptibility, phylogenetic groups, prevalence of flu, fluA CFT073, fluB CFT073, curli and cellulose. High prevalence of multidrug resistance and extended spectrum beta lactamase production was found among Iranian and Vietnamese isolates. Resistance was associated with phylogenetic group D while group B2 was associated with fluA CFT073 and fluB CFT073. Fewer Iranian isolates carried fluA CFT073, curli and cellulose. fluB CFT073 was most prevalent among Slovak isolates. Ampicillin and amoxicillin/clavulanic acid resistance was prevalent among fluA CFT073- and fluB CFT073-positive Australian, Iranian and Swedish isolates. Lack of curli and cellulose was associated with resistance among Vietnamese isolates. We conclude that major differences exist in the prevalence of antibiotic resistance among UPEC from different countries. Associations observed between resistance and virulence factors may, in different ways, promote the long-term survival of UPEC in the urinary tract.
Literature
1.
go back to reference Chakupurakal R, Ahmed M, Sobithadevi DN, Chinnappan S, Reynolds T (2010) Urinary tract pathogens and resistance pattern. J Clin Pathol 63:652–654PubMedCrossRef Chakupurakal R, Ahmed M, Sobithadevi DN, Chinnappan S, Reynolds T (2010) Urinary tract pathogens and resistance pattern. J Clin Pathol 63:652–654PubMedCrossRef
2.
go back to reference Williams G, Craig JC (2009) Prevention of recurrent urinary tract infection in children. Curr Opin Infect Dis 22:72–76PubMedCrossRef Williams G, Craig JC (2009) Prevention of recurrent urinary tract infection in children. Curr Opin Infect Dis 22:72–76PubMedCrossRef
3.
go back to reference Shaikh N, Morone NE, Bost JE, Farrell MH (2008) Prevalence of urinary tract infection in childhood. Pediatr Infect Dis J 27:302–308PubMedCrossRef Shaikh N, Morone NE, Bost JE, Farrell MH (2008) Prevalence of urinary tract infection in childhood. Pediatr Infect Dis J 27:302–308PubMedCrossRef
4.
go back to reference Leroy S, Chalumeau M, Ulinski T, Dubos F, Sergent-Alaoui A, Merzoug V, Ducou-le-Pointe H, Audry G, Gendrel D, Bensman A (2010) Impressive renal damage after acute pyelonephritis in a child. Pediatr Nephrol 25:1365–1368PubMedCrossRef Leroy S, Chalumeau M, Ulinski T, Dubos F, Sergent-Alaoui A, Merzoug V, Ducou-le-Pointe H, Audry G, Gendrel D, Bensman A (2010) Impressive renal damage after acute pyelonephritis in a child. Pediatr Nephrol 25:1365–1368PubMedCrossRef
5.
go back to reference Conway PH, Cnaan A, Zaoutis T, Henry BV, Grunmeier RW, Keren R (2007) Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials. JAMA 298:179–186PubMedCrossRef Conway PH, Cnaan A, Zaoutis T, Henry BV, Grunmeier RW, Keren R (2007) Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials. JAMA 298:179–186PubMedCrossRef
6.
go back to reference Craig JC, Simpson JM, Williams GJ, Lowe A, Reynolds GJ, McTaggart SJ, Hodson EM, Carapetis JR, Cranswick NE, Smith G, Irwig LM, Caldwell PHY, Hamilton S, Roy LP (2009) Antibiotic prophylaxis and recurrent urinary tract infection in children. N Engl J Med 361:1748–1759PubMedCrossRef Craig JC, Simpson JM, Williams GJ, Lowe A, Reynolds GJ, McTaggart SJ, Hodson EM, Carapetis JR, Cranswick NE, Smith G, Irwig LM, Caldwell PHY, Hamilton S, Roy LP (2009) Antibiotic prophylaxis and recurrent urinary tract infection in children. N Engl J Med 361:1748–1759PubMedCrossRef
7.
go back to reference Bitsori M, Maraki S, Kalmanti M, Galanakis E (2009) Resistance against broad-spectrum β-lactams among uropathogens in children. Pediatr Nephrol 24:2381–2386PubMedCrossRef Bitsori M, Maraki S, Kalmanti M, Galanakis E (2009) Resistance against broad-spectrum β-lactams among uropathogens in children. Pediatr Nephrol 24:2381–2386PubMedCrossRef
8.
go back to reference Catal F, Bavbek N, Bayrak O, Karabel M, Karabel D, Odemis E, Uz E (2009) Antimicrobial resistance patterns of urinary tract pathogens and rationale for empirical therapy in Turkish children for the years 2000–2006. Int Urol Nephrol 41:953–957PubMedCrossRef Catal F, Bavbek N, Bayrak O, Karabel M, Karabel D, Odemis E, Uz E (2009) Antimicrobial resistance patterns of urinary tract pathogens and rationale for empirical therapy in Turkish children for the years 2000–2006. Int Urol Nephrol 41:953–957PubMedCrossRef
9.
go back to reference Cheng C-H, Tsau Y-K, Kuo C-Y, Su L-H, Lin T-Y (2010) Comparison of extended virulence genotypes for bacteria isolated from pediatric patients with urosepsis, acute pyelonephritis, and acute lobar nephronia. Pediatr Infect Dis J 29:736–740PubMedCrossRef Cheng C-H, Tsau Y-K, Kuo C-Y, Su L-H, Lin T-Y (2010) Comparison of extended virulence genotypes for bacteria isolated from pediatric patients with urosepsis, acute pyelonephritis, and acute lobar nephronia. Pediatr Infect Dis J 29:736–740PubMedCrossRef
10.
go back to reference Ulett GC, Valle J, Beloin C, Sherlock O, Ghigo J-M, Schembri MA (2007) Functional analysis of antigen 43 in uropathogenic Escherichia coli reveals a role in long-term persistence in the urinary tract. Infect Immun 75:3233–3244PubMedCrossRef Ulett GC, Valle J, Beloin C, Sherlock O, Ghigo J-M, Schembri MA (2007) Functional analysis of antigen 43 in uropathogenic Escherichia coli reveals a role in long-term persistence in the urinary tract. Infect Immun 75:3233–3244PubMedCrossRef
11.
go back to reference Lüthje P, Brauner A (2010) Ag43 promotes persistence of uropathogenic Escherichia coli isolates in the urinary tract. J Clin Microbiol 48:2316–2317PubMedCrossRef Lüthje P, Brauner A (2010) Ag43 promotes persistence of uropathogenic Escherichia coli isolates in the urinary tract. J Clin Microbiol 48:2316–2317PubMedCrossRef
12.
go back to reference Kai-Larsen Y, Lüthje P, Chromek M, Peters V, Wang X, Holm Å, Kadas L, Hedlund K-J, Johansson J, Chapman MR, Jacobson SH, Römling U, Agerberth B, Brauner A (2010) Uropathogenic Escherichia coli modulates immune responses and its curli fimbriae interact with the antimicrobial peptide LL-37. PLoS Pathog 6:e1001010PubMedCrossRef Kai-Larsen Y, Lüthje P, Chromek M, Peters V, Wang X, Holm Å, Kadas L, Hedlund K-J, Johansson J, Chapman MR, Jacobson SH, Römling U, Agerberth B, Brauner A (2010) Uropathogenic Escherichia coli modulates immune responses and its curli fimbriae interact with the antimicrobial peptide LL-37. PLoS Pathog 6:e1001010PubMedCrossRef
13.
go back to reference Cooke NM, Smith SG, Kelleher M, Rogers TR (2010) Major differences exist in frequencies of virulence factors and multidrug resistance between community and nosocomial Escherichia coli bloodstream isolates. J Clin Microbiol 48:1099–1104PubMedCrossRef Cooke NM, Smith SG, Kelleher M, Rogers TR (2010) Major differences exist in frequencies of virulence factors and multidrug resistance between community and nosocomial Escherichia coli bloodstream isolates. J Clin Microbiol 48:1099–1104PubMedCrossRef
14.
go back to reference Johnson JR, Brown JJ (1996) A novel multiply primed polymerase chain reaction assay for identification of variant papG genes encoding the Gal(α1-4)Gal-binding PapG adhesins of Escherichia coli. J Infect Dis 173:920–926PubMedCrossRef Johnson JR, Brown JJ (1996) A novel multiply primed polymerase chain reaction assay for identification of variant papG genes encoding the Gal(α1-4)Gal-binding PapG adhesins of Escherichia coli. J Infect Dis 173:920–926PubMedCrossRef
15.
go back to reference Clermont O, Bonacorsi S, Bingen E (2000) Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 66(10):4555–4558PubMedCrossRef Clermont O, Bonacorsi S, Bingen E (2000) Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 66(10):4555–4558PubMedCrossRef
16.
go back to reference Restieri C, Garriss G, Locas M-C, Dozois CM (2007) Autotransporter-encoding sequences are phylogenetically distributed among Escherichia coli clinical isolates and reference strains. Appl Environ Microbiol 73:1553–1562PubMedCrossRef Restieri C, Garriss G, Locas M-C, Dozois CM (2007) Autotransporter-encoding sequences are phylogenetically distributed among Escherichia coli clinical isolates and reference strains. Appl Environ Microbiol 73:1553–1562PubMedCrossRef
17.
go back to reference Roche AJ, McFadden JP, Owen P (2001) Antigen 43, the major phase-variable protein of the Escherichia coli outer membrane, can exist as a family of proteins encoded by multiple alleles. Microbiology 147:161–169PubMed Roche AJ, McFadden JP, Owen P (2001) Antigen 43, the major phase-variable protein of the Escherichia coli outer membrane, can exist as a family of proteins encoded by multiple alleles. Microbiology 147:161–169PubMed
18.
go back to reference van de Sande-Bruinsma N, Grundmann H, Verloo D, Tiemersma E, Monen J, Goossens H, Ferech M, Groups EARSSGaESoACP (2008) Antimicrobial drug use and resistance in Europe. Emerg Infect Dis 14:1722–1730PubMedCrossRef van de Sande-Bruinsma N, Grundmann H, Verloo D, Tiemersma E, Monen J, Goossens H, Ferech M, Groups EARSSGaESoACP (2008) Antimicrobial drug use and resistance in Europe. Emerg Infect Dis 14:1722–1730PubMedCrossRef
19.
go back to reference Pan Y, Henderson J, Britt H (2006) Antibiotic prescribing in Australian general practice: how has it changed from 1990–91 to 2002–03. Respir Med 100:2004–2011PubMedCrossRef Pan Y, Henderson J, Britt H (2006) Antibiotic prescribing in Australian general practice: how has it changed from 1990–91 to 2002–03. Respir Med 100:2004–2011PubMedCrossRef
20.
go back to reference Mölstad S, Erntell M, Hanberger H, Melander E, Norman C, Skoog G, Lundborg CS, Söderström A, Torell E, Cars O (2008) Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme. Lancet Infect Dis 8:125–132PubMedCrossRef Mölstad S, Erntell M, Hanberger H, Melander E, Norman C, Skoog G, Lundborg CS, Söderström A, Torell E, Cars O (2008) Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme. Lancet Infect Dis 8:125–132PubMedCrossRef
21.
go back to reference Mehrgan H, Rahbar M, Arab-Halvaii Z (2010) High prevalence of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a tertiary care hospital in Tehran, Iran. J Infect Dev Ctries 4:132–138PubMedCrossRef Mehrgan H, Rahbar M, Arab-Halvaii Z (2010) High prevalence of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a tertiary care hospital in Tehran, Iran. J Infect Dev Ctries 4:132–138PubMedCrossRef
22.
go back to reference Duong DV, Binns CW, Le TV (1997) Availability of antibiotics as over-the-counter drugs in pharmacies: a threat to public health in Vietnam. Trop Med Int Health 2:1133–1139PubMedCrossRef Duong DV, Binns CW, Le TV (1997) Availability of antibiotics as over-the-counter drugs in pharmacies: a threat to public health in Vietnam. Trop Med Int Health 2:1133–1139PubMedCrossRef
23.
go back to reference Gaspari RJ, Dickson E, Karlowsky J, Doern G (2006) Multidrug resistance in pediatric urinary tract infections. Microb Drug Resist 12:126–129PubMedCrossRef Gaspari RJ, Dickson E, Karlowsky J, Doern G (2006) Multidrug resistance in pediatric urinary tract infections. Microb Drug Resist 12:126–129PubMedCrossRef
24.
go back to reference Bukh AS, Schønheyder HC, Emmersen JMG, Søgaard M, Bastholm S, Roslev P (2009) Escherichia coli phylogenetic groups are associated with site of infection and level of antibiotic resistance in community-acquired bacteraemia: a 10 year population-based study in Denmark. J Antimicrob Chemother 64:163–168PubMedCrossRef Bukh AS, Schønheyder HC, Emmersen JMG, Søgaard M, Bastholm S, Roslev P (2009) Escherichia coli phylogenetic groups are associated with site of infection and level of antibiotic resistance in community-acquired bacteraemia: a 10 year population-based study in Denmark. J Antimicrob Chemother 64:163–168PubMedCrossRef
25.
go back to reference Johnson JR, Kuskowski MA, Gajewski A, Sahm DF, Karlowsky JA (2004) Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobial-susceptible clinical isolates of Escherichia coli from across the United States, 2000–2001. J Infect Dis 190:1739–1744PubMedCrossRef Johnson JR, Kuskowski MA, Gajewski A, Sahm DF, Karlowsky JA (2004) Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobial-susceptible clinical isolates of Escherichia coli from across the United States, 2000–2001. J Infect Dis 190:1739–1744PubMedCrossRef
26.
go back to reference Narchi H, Al-Hamdani M (2010) Uropathogen resistance to antibiotic prophylaxis in urinary tract infections. Microb Drug Resist 16:151–154PubMedCrossRef Narchi H, Al-Hamdani M (2010) Uropathogen resistance to antibiotic prophylaxis in urinary tract infections. Microb Drug Resist 16:151–154PubMedCrossRef
27.
go back to reference Mabbett AN, Ulett GC, Watts RE, Tree JJ, Totsika M, Ong CL, Wood JM, Monaghan W, Looke DF, Nimmo GR, Svanborg C, Schembri MA (2009) Virulence properties of asymptomatic bacteriuria Escherichia coli. Int J Med Microbiol 299(1):53–63PubMedCrossRef Mabbett AN, Ulett GC, Watts RE, Tree JJ, Totsika M, Ong CL, Wood JM, Monaghan W, Looke DF, Nimmo GR, Svanborg C, Schembri MA (2009) Virulence properties of asymptomatic bacteriuria Escherichia coli. Int J Med Microbiol 299(1):53–63PubMedCrossRef
28.
go back to reference Allsopp LP, Totsika M, Tree JJ, Ulett GC, Mabbett AN, Wells TJ, Kobe B, Beatson SA, Schembri MA (2010) UpaH is a newly identified autotransporter protein that contributes to biofilm formation and bladder colonization by uropathogenic Escherichia coli CFT073. Infect Immun 78(4):1659–1669PubMedCrossRef Allsopp LP, Totsika M, Tree JJ, Ulett GC, Mabbett AN, Wells TJ, Kobe B, Beatson SA, Schembri MA (2010) UpaH is a newly identified autotransporter protein that contributes to biofilm formation and bladder colonization by uropathogenic Escherichia coli CFT073. Infect Immun 78(4):1659–1669PubMedCrossRef
29.
go back to reference Klemm P, Hjerrild L, Gjermansen M, Schembri MA (2004) Structure-function analysis of the self-recognizing Antigen 43 autotransporter protein from Escherichia coli. Mol Microbiol 51:283–296PubMedCrossRef Klemm P, Hjerrild L, Gjermansen M, Schembri MA (2004) Structure-function analysis of the self-recognizing Antigen 43 autotransporter protein from Escherichia coli. Mol Microbiol 51:283–296PubMedCrossRef
30.
go back to reference Lüthje P, Brauner A (2010) Putative link between the virulence-associated gene fluA and fluoroquinolone resistance in uropathogenic E. coli. J Clin Microbiol 48:675–676PubMedCrossRef Lüthje P, Brauner A (2010) Putative link between the virulence-associated gene fluA and fluoroquinolone resistance in uropathogenic E. coli. J Clin Microbiol 48:675–676PubMedCrossRef
31.
go back to reference Ryu J-H, Beuchat LR (2005) Biofilm formation by Escherichia coli O157:H7 on stainless steel: effect of exopolysaccharide and curli production on its resistance to chlorine. Appl Environ Microbiol 71:247–254PubMedCrossRef Ryu J-H, Beuchat LR (2005) Biofilm formation by Escherichia coli O157:H7 on stainless steel: effect of exopolysaccharide and curli production on its resistance to chlorine. Appl Environ Microbiol 71:247–254PubMedCrossRef
32.
go back to reference Uhlich G, Cooke PH, Solomon EB (2006) Analyses of the red-dry-rough phenotype of an Escherichia coli O157:H7 strain and its role in biofilm formation and resistance to antibacterial agents. Appl Environ Microbiol 72:2564–2572PubMedCrossRef Uhlich G, Cooke PH, Solomon EB (2006) Analyses of the red-dry-rough phenotype of an Escherichia coli O157:H7 strain and its role in biofilm formation and resistance to antibacterial agents. Appl Environ Microbiol 72:2564–2572PubMedCrossRef
33.
go back to reference Andersson DI (2006) The biological cost of mutational antibiotic resistance: any practical conclusions? Curr Opin Microbiol 9:461–465PubMedCrossRef Andersson DI (2006) The biological cost of mutational antibiotic resistance: any practical conclusions? Curr Opin Microbiol 9:461–465PubMedCrossRef
Metadata
Title
Characterisation of uropathogenic Escherichia coli from children with urinary tract infection in different countries
Authors
N. L. Ramos
D. T. N. Dzung
K. Stopsack
V. Jankó
M. R. Pourshafie
M. Katouli
A. Brauner
Publication date
01-12-2011
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 12/2011
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-011-1264-4

Other articles of this Issue 12/2011

European Journal of Clinical Microbiology & Infectious Diseases 12/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.